Key facts
- OPERe’s last known valuation is $13.2M (Jun 2025).
- It has raised $2.8M; the latest was Seed Round ($2.8M) in Jun 2025.
- Notable investors include DNX Ventures, 1stRound, Jafco, Seiko Epson, Vertex Ventures Japan.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for OPERe
- ·The full record, as it builds
Funding rounds
No funding rounds for OPERe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OPERe
Developer of a medical communication platform designed to semi-automatically provide explanations to patients using videos and chats on the smartphone in the patient's pocket. The company's platform uses a semi-automated communication function based on the date of admission or examination, allowing videos and materials to be distributed at appropriate times, and confirmation of viewing and comprehension can be made, enabling healthcare professionals to reduce their workload
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2020
- Website
- opere.jp/
- Ownership
- Privately Held (backing)
OPERe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OPERe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OPERe in its N-PORT filings yet. We sweep new filings monthly.